Medication info

Emla 5% Cream

Prescription medicationCream
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Tanabe Pharma Korea Co., Ltd.
Appearance
It is a uniform white cream.
Packaging
1 tube (5 grams) × 5/box
Approval status
Active

MFDS item code 199403237 · Notified 1994.03.12

Summary

Main use
Pain relief during treatment of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect continues for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., venous cannulation, blood sampling), apply about 2g of this medicine for a minimum of 1 hour and a maximum of 5 hours. 2) For minor superficial surgery (e.g., removal of molluscum contagiosum), apply 1.5-2g/10cm2 for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 for a minimum of 2 hours and a maximum of 5 hours. 2. Genital mucosa: For removal of condylomata, apply about 5~10g of this medicine to the treatment site for 5-10 minutes, then remove this medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use the opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes, and do not exceed 10g per treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed when used up to 15 times over 1~2 months.
Children's dosage
○ Infants aged 3 months-12 months: Do not exceed a total amount of 2g or an application area of 16cm2.

Ingredients

Importer
Tanabe Pharma Korea Co., Ltd.

Efficacy & effects

Pain relief during treatment of the skin, genital mucosa, and leg ulcers

  • Surface anesthesia of the skin
  • surface anesthesia of the genital mucosa
  • surface anesthesia of leg ulcers.
View approved original text

This medication is used for surface anesthesia of the skin during the insertion of a needle or superficial surgical procedures. It can also be applied for surface anesthesia of the genital mucosa, for example, before removing condylomas. It is effective for surface anesthesia, especially in areas of leg ulcers, prior to cleansing or superficial surgery. It helps reduce patient discomfort and pain with its various applications for surface anesthesia.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect continues for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., venous cannulation, blood sampling), apply about 2g of this medicine for a minimum of 1 hour and a maximum of 5 hours. 2) For minor superficial surgery (e.g., removal of molluscum contagiosum), apply 1.5-2g/10cm2 for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 for a minimum of 2 hours and a maximum of 5 hours. 2. Genital mucosa: For removal of condylomata, apply about 5~10g of this medicine to the treatment site for 5-10 minutes, then remove this medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use the opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes, and do not exceed 10g per treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed when used up to 15 times over 1~2 months.

Children's dosage

○ Infants aged 3 months-12 months: Do not exceed a total amount of 2g or an application area of 16cm2.

Precautions

This medication is a cream used as a local anesthetic. Caution is advised when using this medication as a rare blood disorder called methemoglobinemia may occur. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, those with heart or lung diseases, infants under 6 months, and those taking oxidizing agents or related medications are more sensitive to this disorder, and careful monitoring is required during use. Symptoms of methemoglobinemia may include a bluish discoloration of the skin or abnormal coloration of the blood; if symptoms worsen, immediate treatment is required to prevent seizures, coma, arrhythmias, or even death. This drug should not be used in patients with a hypersensitivity to one of the ingredients, in areas with wounds, in patients with mucosal surfaces, contact dermatitis, atopic dermatitis, infants under 3 months, infants under 12 months taking drugs that induce methemoglobinemia, and premature infants born before 37 weeks. Patients with a history of anemia or methemoglobinemia, debilitated patients, the elderly, patients with acute diseases, and those with severe liver disease should use this medication with caution. This medication may cause temporary local reactions such as pallor, erythema, swelling, pruritus, and burning; in rare cases, serious allergic reactions such as anaphylactic shock may occur. Avoid using it near the eyes or in the middle ear as it can cause corneal irritation; if it comes into contact with the eyes, rinse immediately with clean water or saline. When used within the recommended dosages, the risk of systemic toxicity is generally low, but caution is needed as excessive use may lead to severe side effects such as central nervous system and cardiac function depression. Combining this medication with certain drugs (e.g., nitrates, anticancer agents, antibiotics, antimalarials, anticonvulsants, etc.) may increase the risk of methemoglobinemia, so consultation with a healthcare professional is necessary. Pregnant women should use this medication only when the benefits outweigh the risks to the fetus, and nursing mothers should be cautious as some components may be secreted in breast milk. Safety and efficacy in children, especially infants under 3 months, have not been sufficiently studied, so it should be used cautiously, and application to the genital mucosa is not recommended. In cases of atopic dermatitis, the application time should be reduced, and prolonged use may result in local reactions such as erythema or bleeding on the skin. When using this medication, the prescribed method and dosage must be adhered to, and if any abnormal symptoms arise, immediate consultation with a healthcare provider is necessary.

Side effects

  • pallor
  • erythema
  • edema
  • initial burning sensation
  • pruritus
  • purpura
  • petechiae
  • methemoglobinemia
  • allergic reactions
  • anaphylactic shock
Show 3 more
  • corneal irritation
  • paresthesia
  • skin irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored at cool room temperature, and it is important to keep it in a tightly sealed container to prevent air or moisture from entering.

Appearance and packaging

Appearance

It is a uniform white cream.

Package unit

1 tube (5 grams) × 5/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.